Our Vision

Wayland is a global leader in providing cannabis-derived consumer and medical products. We consistently deliver on our promise to enhance consumers’ everyday lives through accessible products, and partnerships with like-minded brands and companies. Our medicinal products are researched, developed, and distributed with a patient-centric approach, and we apply the same strict standards to our consumer brands. We are committed to improving the communities where we live and do business, and show our commitment by living our company values every day. We support our business with government relationships that ensure we successfully navigate complex regulatory environments with a focus on safety and accessibility. Our breakthrough R&D and manufacturing practices are at the very heart of our business, and are delivered with close attention to our company’s environmental impact. Our goal is to having the lightest and most sustainable imprint possible.

Press Releases

October 11, 2018

Wayland Group Announces $50 million Bought Deal Financing

Read More
October 10, 2018

Wayland successfully exports THC distillate from Canada to Switzerland

Read More
September 27, 2018

Wayland Announces Plans for First Retail Location in Zurich, Switzerland

Read More
January 9, 2018

Announces Closing of $40 Million Private Placement

Read More
December 14, 2017

Upsize of Previously Announced Private Placement

Read More